Although PYCR1 is conventionally considered to be mainly distributed in the mitochondrial matrix, either immunoblotting or IHC analysis in our study indicates PYCR1 constitutively localizes in the nucleus of tumor cells, implying that PYCR1 would exert a potential subcellular effect on nuclear activities. The gene discussed is PYCR1; the disease is neoplasm.